Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury

Autor: Peter R. Mertens, Jean-Claude Dussaule, Ute Raffetseder, Monique Kerroch, Clemens D. Cohen, Annemarie Dittrich, Sonja Djudjaj, Sabine Brandt, Cheng Zhu, Maja T. Lindenmeyer, Dominique Guerrot, Jürgen Floege, Peter Boor, Christos Chatziantoniou, Lydia Hanssen, Tammo Ostendorf
Přispěvatelé: Department of Nephrology and Immunology, Rheinisch-Westfälische Technische Hochschule Aachen (RWTH), Department of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University [Magdeburg] (OVGU), Remodelage et Reparation du Tissu Renal, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Pathology, Institute of Molecular Biomedicine, Comenius University in Bratislava, Department of Medical Microbiology, Division of nephrology and Institute of Physiology, Universität Zürich [Zürich] = University of Zurich (UZH), This work was supported by fellowship grants from the ERA-ETDA (to S.D.), DFG SFB 854 project 01 (to P.R.M.) and DFG Sachbeihilfeantrag 1365/7-1 (to P.R.M.). C.C. received INSERM funding. U.R was funded by the Else-Kröner-Fresenius- Stiftung., Rheinisch-Westfälische Technische Hochschule Aachen University (RWTH), Otto-von-Guericke-Universität Magdeburg = Otto-von-Guericke University [Magdeburg] (OVGU)
Rok vydání: 2012
Předmět:
MESH: Signal Transduction
MESH: Inflammation
Pathology
Receptor expression
Nephron
030204 cardiovascular system & hematology
MESH: Receptor
Notch1

MESH: Mice
Knockout

[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology
MESH: Biopsy
0302 clinical medicine
MESH: Up-Regulation
MESH: Animals
chemotaxis
Receptor
0303 health sciences
Kidney
Kidney diseases
3. Good health
tubular cells
medicine.anatomical_structure
MESH: Fibrosis
MESH: Membrane Proteins
medicine.symptom
MESH: Nephritis
Interstitial

medicine.medical_specialty
MESH: Rats
proliferation
Notch signaling pathway
Inflammation
Biology
Pathology and Forensic Medicine
03 medical and health sciences
MESH: Mice
Inbred C57BL

MESH: Cell Proliferation
medicine
MESH: Intercellular Signaling Peptides and Proteins
MESH: Mice
MESH: Transforming Growth Factor beta
030304 developmental biology
MESH: Humans
urogenital system
fibrosis
Kidney metabolism
MESH: Kidney
medicine.disease
MESH: Cell Line
inflammation
Notch receptors
MESH: Ureteral Obstruction
MESH: Disease Models
Animal

MESH: Receptors
Notch

MESH: Female
Kidney disease
Zdroj: Journal of Pathology
Journal of Pathology, Wiley, 2012, 228 (3), pp.286-99. ⟨10.1002/path.4076⟩
Journal of Pathology, 2012, 228 (3), pp.286-99. ⟨10.1002/path.4076⟩
ISSN: 0022-3417
1096-9896
DOI: 10.1002/path.4076
Popis: International audience; Kidney diseases impart a vast burden on affected individuals and the overall health care system. Progressive loss of renal parenchymal cells and functional decline following injury are often observed. Notch-1 and -2 receptors are crucially involved in nephron development and contribute to inflammatory kidney diseases. We specifically determined the participation of receptor Notch-3 following tubulointerstitial injury and in inflammatory responses. Here we show by heat map analyses that Notch-3 transcripts are up-regulated in human kidney diseases. A similar response was corroborated with kidney cells following TGF-β exposure in vitro. The murine unilateral ureteral obstruction (UUO) model mirrors hallmarks of tubulointerstitial injury and damage. A subset of tubular and interstitial cells demonstrated up-regulated Notch-3 receptor expression in diseased animals. We hypothesized a relevance of Notch-3 receptors for the chemotactic response. To address this question, animals with genetic ablation of receptor Notch-3 were analysed following UUO. As a result, we found that Notch-3-deficient animals are protected from tubular injury and cell loss with significantly reduced interstitial collagen deposition. Monocytic cell infiltration was significantly reduced and retarded, likely due to abrogated chemokine synthesis. A cell model was set up that mimics enhanced receptor Notch-3 expression and activation. Here a pro-mitogenic response was seen with activated signalling in tubular cells and fibroblasts. In conclusion, Notch-3 receptor fulfils non-redundant roles in the inflamed kidney that may not be replaced by other Notch receptor family members. Thus, specific blockade of this receptor may be suitable as therapeutic option to delay progression of kidney disease.
Databáze: OpenAIRE